Mikel P. Moyer
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Mikel P. Moyer
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Subsidiary | Biotechnology | 9 | |
| Subsidiary | Pharmaceuticals: Major | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Mikel P. Moyer tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| ANIKA THERAPEUTICS, INC. | Medical Specialties | Comptroller/Controller/Auditor | |
| PHARMACYCLICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| NEA 11 GP LLC | Corporate Officer/Principal | ||
| NEA 12 GP LLC | Corporate Officer/Principal | ||
Zyngenia, Inc.
 Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD. | Drugstore Chains | Director/Board Member | |
Closely, Inc.
 Closely, Inc. Miscellaneous Commercial ServicesCommercial Services Closely, Inc. provides mobile and web-based tools that help merchants promote their business and create loyal customers. It specializes in small business marketing, local marketing, SMB, SAAS startup. The company was founded by Karyn German and Perry R. Evans on December 3, 2009 and is headquartered in Denver, CO. | Miscellaneous Commercial Services | Director/Board Member | |
| J.E.M. CAPITAL INC | Financial Conglomerates | Director/Board Member | |
| NEXIMMUNE, INC. | Pharmaceuticals: Major | Director/Board Member | |
| GALERA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
Southern Methodist University
 Southern Methodist University Other Consumer ServicesConsumer Services Southern Methodist University is a private university near the center of Dallas, SMU offers undergraduate, graduate, and professional programs through seven schools in the humanities and sciences, business, the performing, visual, and communication arts, engineering, education and human development, law, and theology. | College/University | Undergraduate Degree Undergraduate Degree | |
Genetic Therapy, Inc.
 Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Genetic Therapy, Inc. develops human gene therapy products for the treatment of genetic and acquired diseases. The company also conducts research on human gene development. Genetic Therapy was founded by M. James Barrett in May 1986 and is headquartered in Gaithersburg, MD. | Miscellaneous Commercial Services | Chief Executive Officer | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Yale University | College/University | Undergraduate Degree | |
| IOMAI CORPORATION | Biotechnology | Director/Board Member | |
Senseonics, Inc.
 Senseonics, Inc. Electronic ComponentsElectronic Technology Senseonics, Inc. develops transformative glucose monitoring products. It develops Senseonics continuous glucose monitoring system, an implantable continuous glucose monitoring system, which includes a miniaturized sensor and receiver that is inserted into the subcutaneous space under the skin to wirelessly transmit glucose levels to an external receiver. The company was founded by Michael James Barrett and Arthur E. Colvin in 1996 and is headquartered in Germantown, MD. | Electronic Components | Founder | |
23andMe, Inc.
 23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Medical Specialties | Corporate Officer/Principal | |
New England Venture Capital Association, Inc.
 New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
| Smithkline Clinical Laboratories | President | ||
| Bethesda Research Laboratories, Inc. | Chief Executive Officer | ||
| NEA 13 GP Ltd. | Director/Board Member | ||
| CLOVIS ONCOLOGY, INC. | Pharmaceuticals: Major | Chairman | |
| BICYCLE THERAPEUTICS PLC | Biotechnology | Director/Board Member | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
Impresa Management LLC
 Impresa Management LLC Investment ManagersFinance Impresa Management LLC(Impresa Management) is a Private Equity/Venture Capital firm, a subsidiary of Devonshire Investors LLC founded in 1946.The firm is headquartered in Boston. | Investment Managers | Founder | |
| REPLIMUNE GROUP, INC. | Biotechnology | Director/Board Member | |
| SENSEONICS HOLDINGS, INC. | Electronic Components | Director/Board Member | |
Gemini Therapeutics Sub, Inc.
 Gemini Therapeutics Sub, Inc. BiotechnologyHealth Technology Gemini Therapeutics Sub, Inc. engages in the development of treatments for age-related macular degeneration (AMD) and linked ocular disorders. Its multimodal pipeline includes monoclonal antibodies, recombinant proteins and gene therapies. The company was founded by James McLaughlin, Johanna Seddon, Paul Barlow and Andrew Herbert in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| Lomai Corp. | Director/Board Member | ||
Placon Therapeutics, Inc.
 Placon Therapeutics, Inc. BiotechnologyHealth Technology Placon Therapeutics, Inc. develops novel platinum therapies. The private company is based in Watertown. | Biotechnology | Director/Board Member | |
Disarm Therapeutics, Inc.
 Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer | |
| GENERATION BIO CO. | Pharmaceuticals: Major | Founder | |
Accent Therapeutics, Inc.
 Accent Therapeutics, Inc. BiotechnologyHealth Technology Accent Therapeutics, Inc. operates as a biopharmaceutical company which develops treatments for cancer patients. The company was founded by Howard Y. Chang, Chuan He and Robert A. Copeland in September 2017 and is headquartered in Lexington, MA. | Biotechnology | Director/Board Member | |
| DYNE THERAPEUTICS, INC. | Biotechnology | Founder | |
Roka Bioscience, Inc.
 Roka Bioscience, Inc. BiotechnologyHealth Technology Roka Bioscience, Inc. is a company that specializes in food safety technology. The company is based in Mendham, NJ and was founded in 2009 by Paul G. Thomas. Roka Bioscience's core technology is their pathogen detection assays which combine the power of target capture, transcription-mediated amplification, and hybridization protection assay to target ribosomal RNA (rRNA), an optimal target for molecular technology in food pathogen detection applications. The company offers a range of products including the Atlas® System and various detection assays for E. coli, Listeria, Salmonella, Campylobacter, and Legionella. Roka Bioscience also provides environmental testing solutions and technical support for their customers. Mary Duseau has been the CEO of the company since 2015. | Biotechnology | Director/Board Member | |
| 23ANDME HOLDING CO. | Biotechnology | Corporate Officer/Principal | |
| ZOSANO PHARMA CORPORATION | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 49 |
| Hong Kong | 2 |
| Regno Unito | 2 |
Settori
| Health Technology | 32 |
| Commercial Services | 4 |
| Finance | 4 |
| Consumer Services | 4 |
| Electronic Technology | 3 |
Posizioni
| Director/Board Member | 97 |
| Corporate Officer/Principal | 35 |
| Independent Dir/Board Member | 27 |
| Chairman | 25 |
| Chief Executive Officer | 14 |
Contatti più connessi
| Insiders | |
|---|---|
| Michael Barrett | 49 |
| Thomas Daniel | 35 |
| Ho Young Huh | 32 |
| Jason Rhodes | 24 |
| Victoria Richon | 11 |
| Jennifer Low | 9 |
| Eric Hedrick | 7 |
| Jacob van Naarden | 7 |
| Alicja Januszewicz | 7 |
| Stephen Garbacz | 6 |
| Zoran Zdraveski | 6 |
| Aidan Finley | 1 |
- Borsa valori
- Insiders
- Mikel P. Moyer
- Connessioni Società